A detailed history of Voya Investment Management LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 58,990 shares of ARVN stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,990
Previous 59,517 0.89%
Holding current value
$1.13 Million
Previous $1.58 Million 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.66 - $32.73 $12,468 - $17,248
-527 Reduced 0.89%
58,990 $1.45 Million
Q2 2024

Dec 03, 2024

BUY
$24.46 - $40.4 $12,890 - $21,290
527 Added 0.89%
59,517 $1.58 Million
Q2 2024

Aug 14, 2024

BUY
$24.46 - $40.4 $24,411 - $40,319
998 Added 1.71%
59,517 $1.58 Million
Q1 2024

Dec 06, 2024

SELL
$36.38 - $52.31 $17,134 - $24,638
-471 Reduced 0.8%
58,519 $2.42 Million
Q1 2024

May 15, 2024

BUY
$36.38 - $52.31 $772,274 - $1.11 Million
21,228 Added 56.93%
58,519 $2.42 Million
Q4 2023

Feb 14, 2024

SELL
$14.19 - $42.33 $766 - $2,285
-54 Reduced 0.14%
37,291 $1.53 Million
Q3 2023

Nov 14, 2023

BUY
$19.64 - $28.21 $4,536 - $6,516
231 Added 0.62%
37,345 $733,000
Q2 2023

Aug 14, 2023

SELL
$21.73 - $31.43 $1.02 Million - $1.48 Million
-47,111 Reduced 55.93%
37,114 $921,000
Q1 2023

May 15, 2023

BUY
$26.15 - $37.26 $1,464 - $2,086
56 Added 0.07%
84,225 $2.3 Million
Q4 2022

Feb 14, 2023

SELL
$32.47 - $57.24 $794,183 - $1.4 Million
-24,459 Reduced 22.52%
84,169 $2.88 Million
Q3 2022

Mar 03, 2023

BUY
$41.87 - $57.99 $1.02 Million - $1.42 Million
24,459 Added 29.06%
108,628 $4.83 Million
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $1.81 Million - $2.51 Million
43,274 Added 66.21%
108,628 $4.83 Million
Q2 2022

Aug 15, 2022

BUY
$36.01 - $74.24 $35,109 - $72,384
975 Added 1.51%
65,354 $2.75 Million
Q1 2022

May 16, 2022

SELL
$60.27 - $81.57 $998,071 - $1.35 Million
-16,560 Reduced 20.46%
64,379 $4.33 Million
Q4 2021

Feb 14, 2022

SELL
$65.85 - $96.21 $6.26 Million - $9.14 Million
-95,027 Reduced 54.0%
80,939 $6.65 Million
Q3 2021

Nov 15, 2021

BUY
$73.2 - $107.87 $10.1 Million - $14.8 Million
137,619 Added 358.88%
175,966 $14.5 Million
Q2 2021

Aug 16, 2021

BUY
$60.45 - $84.26 $1.36 Million - $1.9 Million
22,508 Added 142.1%
38,347 $2.95 Million
Q1 2021

May 17, 2021

BUY
$58.19 - $91.37 $76,810 - $120,608
1,320 Added 9.09%
15,839 $1.05 Million
Q4 2020

Feb 16, 2021

BUY
$20.19 - $84.93 $88,068 - $370,464
4,362 Added 42.95%
14,519 $1.23 Million
Q2 2020

Aug 14, 2020

SELL
$29.88 - $56.74 $15,537 - $29,504
-520 Reduced 4.87%
10,157 $341,000
Q1 2020

May 15, 2020

BUY
$33.0 - $54.5 $12,012 - $19,838
364 Added 3.53%
10,677 $430,000
Q4 2019

Feb 14, 2020

BUY
$15.39 - $44.38 $158,717 - $457,690
10,313 New
10,313 $424,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.